S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
NYSE:ALC

Alcon Stock Forecast, Price & News

$77.91
-0.68 (-0.87%)
(As of 01/18/2022 12:00 AM ET)
Add
Compare
Today's Range
$77.62
$78.75
50-Day Range
$77.91
$88.50
52-Week Range
$65.60
$88.78
Volume
881,062 shs
Average Volume
841,097 shs
Market Capitalization
$38.04 billion
P/E Ratio
116.28
Dividend Yield
N/A
Beta
0.65
30 days | 90 days | 365 days | Advanced Chart
Receive ALC News and Ratings via Email

Sign-up to receive the latest news and ratings for Alcon and its competitors with MarketBeat's FREE daily newsletter.


Alcon logo

About Alcon

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Fribourg, Switzerland.

Headlines

Analyst Ratings For Alcon - Benzinga - Benzinga
January 7, 2022 |  benzinga.com
See More Headlines

Industry, Sector and Symbol

Industry
Ophthalmic goods
Sub-Industry
Health Care Facilities
Sector
Medical
CUSIP
04544X30
Employees
23,655
Year Founded
1945

Sales & Book Value

Annual Sales
$6.83 billion
Cash Flow
$4.34 per share
Book Value
$38.55 per share

Profitability

Net Income
$-531 million
Pretax Margin
4.71%

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
$38.04 billion
Optionable
Not Optionable

Company Calendar

Last Earnings
11/08/2021
Today
1/19/2022
Next Earnings (Estimated)
2/22/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank

Overall MarketRank

1.75 out of 5 stars

Medical Sector

908th out of 1,414 stocks

Ophthalmic Goods Industry

4th out of 5 stocks

Analyst Opinion: 2.3Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 1.3 5 -4 -3 -2 -1 -












Alcon (NYSE:ALC) Frequently Asked Questions

Is Alcon a buy right now?

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alcon in the last twelve months. There are currently 7 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Alcon stock.
View analyst ratings for Alcon
or view top-rated stocks.

How has Alcon's stock price been impacted by COVID-19?

Alcon's stock was trading at $54.20 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ALC shares have increased by 43.7% and is now trading at $77.91.
View which stocks have been most impacted by COVID-19
.

When is Alcon's next earnings date?

Alcon is scheduled to release its next quarterly earnings announcement on Tuesday, February 22nd 2022.
View our earnings forecast for Alcon
.

How were Alcon's earnings last quarter?

Alcon Inc. (NYSE:ALC) announced its quarterly earnings results on Monday, November, 8th. The healthcare company reported $0.54 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.50 by $0.04. The healthcare company had revenue of $2.08 billion for the quarter, compared to analysts' expectations of $2.04 billion. Alcon had a trailing twelve-month return on equity of 5.22% and a net margin of 4.11%.
View Alcon's earnings history
.

How often does Alcon pay dividends? What is the dividend yield for Alcon?

Alcon announced a -- dividend on Monday, May 3rd. Investors of record on Wednesday, May 5th will be paid a dividend of $0.1103 per share on Thursday, May 6th. This represents a yield of 0.15%. The ex-dividend date is Tuesday, May 4th.
View Alcon's dividend history
.

What price target have analysts set for ALC?

14 brokers have issued 1 year target prices for Alcon's stock. Their forecasts range from $74.00 to $95.00. On average, they expect Alcon's share price to reach $85.70 in the next year. This suggests a possible upside of 10.0% from the stock's current price.
View analysts' price targets for Alcon
or view top-rated stocks among Wall Street analysts.

Who are Alcon's key executives?

Alcon's management team includes the following people:
  • David J. Endicott, Chief Executive Officer & Director
  • Timothy C. Stonesifer, Chief Financial Officer & Senior Vice President
  • Franck Leveiller, Head-Global Research & Development
  • Sue-Jean Lin, Chief Information Officer & Senior Vice President
  • Royce R. Bedward, Secretary, Senior Vice President & General Counsel

What is Greg D. Wight's approval rating as Alcon's CEO?

6 employees have rated Alcon CEO Greg D. Wight on Glassdoor.com. Greg D. Wight has an approval rating of 100% among Alcon's employees. This puts Greg D. Wight in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Alcon own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alcon investors own include AT&T (T), Novartis (NVS), Verizon Communications (VZ), International Business Machines (IBM), Intel (INTC), Pfizer (PFE), Cisco Systems (CSCO), Johnson & Johnson (JNJ), Exxon Mobil (XOM) and AbbVie (ABBV).

What is Alcon's stock symbol?

Alcon trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALC."

Who are Alcon's major shareholders?

Alcon's stock is owned by many different institutional and retail investors. Top institutional investors include Capital Investment Services of America Inc. (0.05%), First Fiduciary Investment Counsel Inc. (0.00%), M&G Investment Management Ltd. (0.03%), Chesley Taft & Associates LLC (0.01%), Crossmark Global Holdings Inc. (0.01%) and Gateway Investment Advisers LLC (0.00%).

Which major investors are selling Alcon stock?

ALC stock was sold by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC, Capital Investment Services of America Inc., M&G Investment Management Ltd., 17 Capital Partners LLC, Fulton Bank N.A., and Wedbush Securities Inc..

Which major investors are buying Alcon stock?

ALC stock was bought by a variety of institutional investors in the last quarter, including Cutler Group LP, First Fiduciary Investment Counsel Inc., Arlington Partners LLC, Spire Wealth Management, Gateway Investment Advisers LLC, Chesley Taft & Associates LLC, Crossmark Global Holdings Inc., and Marotta Asset Management.

How do I buy shares of Alcon?

Shares of ALC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Alcon's stock price today?

One share of ALC stock can currently be purchased for approximately $77.91.

How much money does Alcon make?

Alcon has a market capitalization of $38.04 billion and generates $6.83 billion in revenue each year. The healthcare company earns $-531 million in net income (profit) each year or $0.67 on an earnings per share basis.

How many employees does Alcon have?

Alcon employs 23,655 workers across the globe.

When was Alcon founded?

Alcon was founded in 1945.

What is Alcon's official website?

The official website for Alcon is www.alcon.com.

Where are Alcon's headquarters?

Alcon is headquartered at Rue Louis-d`Affry 6, Fribourg V8, 1701.

How can I contact Alcon?

Alcon's mailing address is Rue Louis-d`Affry 6, Fribourg V8, 1701. The healthcare company can be reached via phone at 41-58-911-2000, via email at [email protected], or via fax at 41-58-911-3222.


This page was last updated on 1/19/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.